Results 261 to 270 of about 868,914 (412)

Microsatellite Instability in the Adenoma-Carcinoma Sequence of the Stomach [PDF]

, 2000
Hee Sung Kim, Dong-Kyun Woo, Soo In Bae, Yong Il Kim, Woo Ho Kim   +4 more
openalex   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

<i>MLH1</i> Methylation Status and Microsatellite Instability in Patients with Colorectal Cancer. [PDF]

Genes (Basel)
Rico-Méndez MA, Trujillo-Rojas MA, Ayala-Madrigal ML, Hernández-Sandoval JA, González-Mercado A, Gutiérrez-Angulo M, Romero-Quintana JG, Valenzuela-Pérez JA, Ramírez-Ramírez R, Flores-López BA, Moreno-Ortiz JM.   +10 more
europepmc   +1 more source

Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis [PDF]

, 2000
Kazuhiro Kashiwagi, Mamoru Watanabe, Taisuke Ezaki, Takanori Kanai∥, Hiromasa Ishii, Masaru Mukai, Toshifumi Hibi∥   +6 more
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Long-term remission of microsatellite instability-high adenosquamous carcinoma in gastric antrum: a case report. [PDF]

Front Oncol
Zhang P, Yang J, Liu Y, Zhou Q, Xue C, Zhang B, Li Y.   +6 more
europepmc   +1 more source

Microsatellite instability in tumors as a model to study the process of microsatellite mutations [PDF]

, 2000
Rosane Sturzeneker
openalex   +1 more source

Adenocarcinoma of the Colon and Microsatellite Instability [PDF]

Mayo Clinic Proceedings, 2018
openaire   +2 more sources

Epacadostat Overcomes Cetuximab Resistance in Colorectal Cancer by Targeting IDO‐Mediated Tryptophan Metabolism

Cancer Science, EarlyView.
The effect of cetuximab and epacadostat combinative therapy on CRC cells. ABSTRACT Primary or acquired mutations in RAS/RAF genes resulting in cetuximab resistance have limited its clinical application in colorectal cancer (CRC) patients. The mechanism of this resistance remains unclear.
Yimin Zhou, Qiongyan Tao, Chubin Luo, Jinsong Chen, Genwen Chen, Jianyong Sun   +5 more
wiley   +1 more source

Immunotherapy-induced microsatellite instability status shift in recurrent perihilar cholangiocarcinoma: A case report. [PDF]

Hum Vaccin Immunother
Yu H, Deng T, Liu H.
europepmc   +1 more source